John Lusingu
Overview
Explore the profile of John Lusingu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
3981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hjort L, Wewer Albrechtsen N, Minja D, Rasmussen C, Moller S, Lusingu J, et al.
J Endocr Soc
. 2023 Oct;
7(10):bvad120.
PMID: 37795192
Context: Anemia and malaria are global health problems affecting >50% of pregnant women in sub-Saharan Africa and are associated with intrauterine growth restriction. The hormones fibroblast growth factor 21 (FGF-21)...
2.
Valles-Colomer M, Blanco-Miguez A, Manghi P, Asnicar F, Dubois L, Golzato D, et al.
Nature
. 2023 Jan;
614(7946):125-135.
PMID: 36653448
The human microbiome is an integral component of the human body and a co-determinant of several health conditions. However, the extent to which interpersonal relations shape the individual genetic makeup...
3.
Nydahl T, Ahorhorlu S, Ndiaye M, Das M, Hansson H, Bravo M, et al.
Am J Trop Med Hyg
. 2021 Jul;
105(4):1085-1092.
PMID: 34270452
The emergence of artemisinin-resistant Plasmodium falciparum parasites in Southeast Asia threatens malaria control and elimination. The interconnectedness of parasite populations may be essential to monitor the spread of resistance. Combining...
4.
RTSS Epidemiology EPI-MAL-005 Study Group The RTSS Epidemiology EPI-MAL-005 Study Group Is Composed Of Per Alphabetical Order , Adeniji E, Asante K, Boahen O, Compaore G, Coulibaly B, et al.
Am J Trop Med Hyg
. 2020 Sep;
103(5):1883-1892.
PMID: 32959764
RTS,S/AS01 malaria vaccine safety, effectiveness, and impact will be assessed in pre- and post-vaccine introduction studies, comparing the occurrence of malaria cases and adverse events in vaccinated versus unvaccinated children....
5.
Manouana G, Lorenz E, Mbong Ngwese M, Nguema Moure P, Maiga Ascofare O, Akenten C, et al.
PLoS Negl Trop Dis
. 2020 Jul;
14(7):e0008448.
PMID: 32658930
Background: Cryptosporidium is a protozoan parasite that causes mild to severe diarrhoeal disease in humans. To date, several commercial companies have developed rapid immunoassays for the detection of Cryptosporidium infection....
6.
Grunnet L, Hjort L, Minja D, Msemo O, Moller S, Prasad R, et al.
Int J Environ Res Public Health
. 2020 May;
17(9).
PMID: 32365670
Gestational diabetes mellitus (GDM) is associated with poor pregnancy outcomes and increased long-term risk of metabolic diseases for both mother and child. In Tanzania, GDM prevalence increased from 0% in...
7.
Lyimo E, Haslund L, Ramsing T, Wang C, Efunshile A, Manjurano A, et al.
Infect Immun
. 2019 Dec;
88(3).
PMID: 31871101
Severe malaria is mostly caused by resulting in considerable, systemic inflammation and pronounced endothelial activation. The endothelium forms an interface between blood and tissue, and vasculopathy has previously been linked...
8.
Otieno L, Mendoza Y, Adjei S, Agbenyega T, Agnandji S, Aide P, et al.
Vaccine
. 2019 Nov;
38(4):897-906.
PMID: 31708182
Background: We assessed the safety and immunogenicity of the RTS,S/AS01 malaria vaccine in a subset of children identified as HIV-infected during a large phase III randomized controlled trial conducted in...
9.
Tett A, Huang K, Asnicar F, Fehlner-Peach H, Pasolli E, Karcher N, et al.
Cell Host Microbe
. 2019 Oct;
26(5):666-679.e7.
PMID: 31607556
Prevotella copri is a common human gut microbe that has been both positively and negatively associated with host health. In a cross-continent meta-analysis exploiting >6,500 metagenomes, we obtained >1,000 genomes...
10.
Tinto H, Otieno W, Gesase S, Sorgho H, Otieno L, Liheluka E, et al.
Lancet Infect Dis
. 2019 Jul;
19(8):821-832.
PMID: 31300331
Background: Results from a previous phase 3 study showed efficacy of the RTS,S/AS01 vaccine against severe and clinical malaria in children (in 11 sites in Africa) during a 3-4-year follow-up....